CGCV - ETF AI Analysis
Top Page
Capital Group Conservative Equity ETF (CGCV)
Rating:70Outperform
Price Target:―
Positive Factors
Broad Sector Diversification
The ETF spreads its investments across many sectors like technology, health care, financials, consumer stocks, and utilities, which helps reduce the impact if any one industry struggles.
Generally Strong Recent Performance
The fund’s returns over the year to date and the last few months have been solid, suggesting its overall mix of holdings has been working well for investors recently.
Multiple Strong Top Holdings
Several of the largest positions, including Broadcom, Philip Morris, Eli Lilly, Apple, Cisco, Starbucks, JPMorgan, and AbbVie, have shown strong gains this year, supporting the ETF’s performance.
Negative Factors
Heavy U.S. Concentration
With almost all assets in U.S. companies and very little in other countries, the fund is highly exposed to the U.S. market and offers limited global diversification.
Mixed Results Among Top Stocks
Some major holdings like Microsoft and Meta have been weak this year, which can drag on the fund’s overall returns despite strength elsewhere.
Moderate Expense Ratio
The ETF’s fee is not extremely high but is also not among the very lowest, meaning investors give up a modest portion of returns to cover costs each year.
CGCV vs. SPDR S&P 500 ETF (SPY)
AUM2.11B
RegionNorth America
Expense Ratio0.33%
Beta0.69
IssuerCapital Group
Inception DateJun 25, 2024
Dividend Yield1.57%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume343,604
30 Day Avg. Volume284,604
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
38.97Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering73
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CGCV Summary
Capital Group Conservative Equity ETF (CGCV) is a stock fund that aims for steady, long-term growth with less ups and downs. It doesn’t track a specific index, but follows a conservative total-market approach, mainly in U.S. companies across many sectors like technology, health care, and financials. Top holdings include well-known names such as Microsoft and Apple. Investors might consider CGCV for broad diversification while focusing on large, established businesses that tend to be more stable. A key risk is that it still invests in stocks, so its value can go up and down with the overall market.
How much will it cost me?The Capital Group Conservative Equity ETF (CGCV) has an expense ratio of 0.33%, which means you’ll pay $3.30 per year for every $1,000 invested. This expense ratio is slightly higher than average for passively managed ETFs because it follows a conservative equity strategy that requires more active management to select high-quality, stable companies.
What would affect this ETF?The Capital Group Conservative Equity ETF (CGCV) could benefit from continued growth in the technology sector, which makes up a significant portion of its holdings, as well as stable performance from large-cap companies like Microsoft and Apple. However, rising interest rates or economic slowdowns could negatively impact sectors like financials and consumer cyclical, which are also key components of the ETF. Additionally, regulatory changes in North America could influence the performance of top holdings such as Meta Platforms and JPMorgan Chase.
CGCV Top 10 Holdings
CGCV leans heavily on U.S. blue-chip tech, with Microsoft, Apple, and Meta doing much of the heavy lifting. Apple and Meta have been rising smartly, giving the fund a strong growth engine, while Microsoft’s more mixed recent run keeps expectations in check. Broadcom and Cisco add to the semiconductor and networking theme, though Broadcom’s softer stretch has been a mild drag. Outside tech, steady gains from Philip Morris and AbbVie help smooth the ride, underscoring the fund’s conservative, North America–focused tilt.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Microsoft | 6.18% | $130.03M | $3.97T | 4.72% | 79 Outperform | |
| Broadcom | 4.05% | $85.11M | $1.73T | 11.37% | 76 Outperform | |
| Philip Morris | 3.61% | $75.81M | $313.58B | 25.38% | 61 Neutral | |
| Apple | 3.09% | $65.06M | $4.91T | 37.25% | 79 Outperform | |
| Cisco Systems | 3.04% | $63.90M | $466.76B | 74.26% | 77 Outperform | |
| Eli Lilly & Co | 3.04% | $63.84M | $1.11T | 41.48% | 72 Outperform | |
| AbbVie | 2.72% | $57.27M | $488.55B | 19.94% | 66 Neutral | |
| Meta Platforms | 2.66% | $56.02M | $1.83T | 1.90% | 76 Outperform | |
| Starbucks | 2.41% | $50.72M | $103.45B | 15.66% | 56 Neutral | |
| JPMorgan Chase | 2.37% | $49.72M | $885.15B | 10.67% | 72 Outperform |
CGCV Technical Analysis
Positive
―
Price Trends
32.89
Negative
32.62
Positive
31.65
Positive
Market Momentum
-0.03
Negative
57.54
Neutral
85.44
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For CGCV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 32.42, equal to the 50-day MA of 32.89, and equal to the 200-day MA of 31.65, indicating a neutral trend. The MACD of -0.03 indicates Negative momentum. The RSI at 57.54 is Neutral, neither overbought nor oversold. The STOCH value of 85.44 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CGCV.
CGCV Peer Comparison
Comparison Results
Performance Comparison
CGCV
Capital Group Conservative Equity ETF
32.85
3.38
11.47%
QLTY
GMO U.S. Quality ETF
―
―
―
TSPA
T. Rowe Price U.S. Equity Research ETF
―
―
―
AKRE
Akre Focus ETF
―
―
―
DCOR
Dimensional US Core Equity 1 ETF
―
―
―
CCFE
Concourse Capital Focused Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents